These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2219737)

  • 1. Effect of two novel inhibitors of the human immunodeficiency virus protease on the maturation of the HIV gag and gag-pol polyproteins.
    Overton HA; McMillan DJ; Gridley SJ; Brenner J; Redshaw S; Mills JS
    Virology; 1990 Nov; 179(1):508-11. PubMed ID: 2219737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphogenic capabilities of human immunodeficiency virus type 1 gag and gag-pol proteins in insect cells.
    Hughes BP; Booth TF; Belyaev AS; McIlroy D; Jowett J; Roy P
    Virology; 1993 Mar; 193(1):242-55. PubMed ID: 8438569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
    Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.
    Sei S; Yang QE; O'Neill D; Yoshimura K; Nagashima K; Mitsuya H
    J Virol; 2000 May; 74(10):4621-33. PubMed ID: 10775598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
    Karacostas V; Wolffe EJ; Nagashima K; Gonda MA; Moss B
    Virology; 1993 Apr; 193(2):661-71. PubMed ID: 7681610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maturation of human immunodeficiency virus particles assembled from the gag precursor protein requires in situ processing by gag-pol protease.
    Ross EK; Fuerst TR; Orenstein JM; O'Neill T; Martin MA; Venkatesan S
    AIDS Res Hum Retroviruses; 1991 May; 7(5):475-83. PubMed ID: 1873082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of viral fitness associated with multiple Gag and Gag-Pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors in vivo.
    Zennou V; Mammano F; Paulous S; Mathez D; Clavel F
    J Virol; 1998 Apr; 72(4):3300-6. PubMed ID: 9525657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of human immunodeficiency virus type-1 protease activity in insect cells expressing Gag-Pol rescues assembly of immature but not mature virus-like particles.
    Adamson CS; Nermut M; Jones IM
    Virology; 2003 Mar; 308(1):157-65. PubMed ID: 12706099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of human immunodeficiency virus type 1 Pr55(Gag) and Pr160(Gag-pol) processing intermediates that accumulate in primary and transformed cells treated with peptidic and nonpeptidic protease inhibitors.
    Speck RR; Flexner C; Tian CJ; Yu XF
    Antimicrob Agents Chemother; 2000 May; 44(5):1397-403. PubMed ID: 10770790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of inhibition of the retroviral protease by a Rous sarcoma virus peptide substrate representing the cleavage site between the gag p2 and p10 proteins.
    Cameron CE; Grinde B; Jentoft J; Leis J; Weber IT; Copeland TD; Wlodawer A
    J Biol Chem; 1992 Nov; 267(33):23735-41. PubMed ID: 1331099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in p1-p6/p6* of HIV type 1 can delay protease autoprocessing and increase drug susceptibility.
    Whitehurst N; Chappey C; Petropoulos C; Parkin N; Gamarnik A
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):779-84. PubMed ID: 14585208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
    McQuade TJ; Tomasselli AG; Liu L; Karacostas V; Moss B; Sawyer TK; Heinrikson RL; Tarpley WG
    Science; 1990 Jan; 247(4941):454-6. PubMed ID: 2405486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of human immunodeficiency virus type 1 protease inhibitors against the initial autocleavage in Gag-Pol polyprotein processing.
    Davis DA; Soule EE; Davidoff KS; Daniels SI; Naiman NE; Yarchoan R
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3620-8. PubMed ID: 22508308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues.
    Meek TD; Lambert DM; Dreyer GB; Carr TJ; Tomaszek TA; Moore ML; Strickler JE; Debouck C; Hyland LJ; Matthews TJ
    Nature; 1990 Jan; 343(6253):90-2. PubMed ID: 1688646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles.
    Chen SW; Chiu HC; Liao WH; Wang FD; Chen SS; Wang CT
    Virology; 2004 Jan; 318(2):534-41. PubMed ID: 14972522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2.
    Schubert U; Ott DE; Chertova EN; Welker R; Tessmer U; Princiotta MF; Bennink JR; Krausslich HG; Yewdell JW
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13057-62. PubMed ID: 11087859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 protease regulation: the role of the major homology region and adjacent C-terminal capsid sequences.
    Gatlin J; Arrigo SJ; Schmidt MG
    J Biomed Sci; 1998; 5(4):305-8. PubMed ID: 9691224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gag-Pol supplied in trans is efficiently packaged and supports viral function in human immunodeficiency virus type 1.
    Hill MK; Hooker CW; Harrich D; Crowe SM; Mak J
    J Virol; 2001 Aug; 75(15):6835-40. PubMed ID: 11435562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro.
    Kotler M; Simm M; Zhao YS; Sova P; Chao W; Ohnona SF; Roller R; Krachmarov C; Potash MJ; Volsky DJ
    J Virol; 1997 Aug; 71(8):5774-81. PubMed ID: 9223465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
    Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
    Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.